<DOC>
	<DOCNO>NCT00716950</DOCNO>
	<brief_summary>Hypertensive patient moderate hypertension risk develop cardiovascular event 15-20 % period 10 year . It important reach quickly advise target , often result obtain combination therapy . Some evidence demonstrate sartans calcium channel blocker useful safe , also important verify association give side effect give pharmacokinetic interaction negatively influence clinical combination efficacy .</brief_summary>
	<brief_title>Valsartan Amlodipine Compared Losartan Amlodipine Hypertensive Patients</brief_title>
	<detailed_description />
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<mesh_term>Amlodipine , Valsartan Drug Combination</mesh_term>
	<criteria>diastolic blood pressure sit position 100 109 mmHg systolic blood pressure &gt; 140 mmHg end selection period type 2 diabetes mellitus heart failure AMI previous 6 month angina pectoris secondary hypertension malignant hypertension woman childbearing potential woman pregnant lactate suspected history allergy sartans calcium channel blocker</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>